Sales Growth YoY (Last 12 Months): NexImmune, Inc. (NEXI)

Public company logo of NexImmune Corporation (NEXI)

The rolling period YoY sales growth trajectory for NexImmune, Inc. (NEXI) shows a decline, as the 0.00 level represents the current value. Cost optimization is achieved by outsourcing all trials to external contractors. However, the potential of the AIM platform to develop anti-cancer agents is offset by a critical shortage of funds. Currently, business operations have virtually ceased, creating a real threat of delisting from the exchange.

NexImmune (NEXI) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 02/20/2024

NexImmune (NEXI) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:NexImmune, Inc.
Product sample of neximmune.com

Assessing stock reliability requires analyzing business scaling rates by comparing current annual revenue with the same period of the previous cycle. This calculation reveals the operational efficiency of NexImmune, Inc. (NEXI) in commercializing its artificial antigen-presenting cell platform, utilizing 12-month year-over-year revenue dynamics to determine how successfully the precise immune retraining technology is transforming into actual financial growth.

Competitors of NexImmune, Inc. (NEXI)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) XNCR|Sales Growth YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Revenue Dynamics YoY (Last Twelve Months) REPL|lyell.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Innate Pharma S.A|Pyxis (PYXS) - Sales Growth YoY (Last Twelve Months)|Compugen Ltd - Revenue Dynamics YoY (Last Twelve Months)|IOBT (iobiotech.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) Sutro Biopharma Inc.|Sales Growth YoY (Last Twelve Months) MiNK Therapeutics (INKT)|HOWL: Trailing Twelve Months Sales Growth|Immix Biopharma - Revenue Growth YoY (Last 12 Months)|ALX Oncology (ALXO) - Trailing Twelve Months Revenue Growth|CUE: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth PDSB|sonnetbio.com (SONN) - Sales Growth YoY (Last Twelve Months)|MAIA Biotechnology Inc (MAIA) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) liminatuspharma.com|Sales Growth YoY (Last Twelve Months) LVTX|Revenue Growth YoY (Last 12 Months) NXTC (NextCure, Inc.)|LPTX: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) intensitytherapeutics.com INTS|Sensei Bio (SNSE) - Trailing Twelve Months Revenue Growth|TOVX: Revenue Growth YoY (Last 12 Months)|Gritstone bio - Revenue Change YoY (Last 12 Months)|Kineta Bio (KA) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)